首页>投融资
Ossium Health
C轮
Ossium Health Inc is a bioengineering company that provides develops bone marrow.In July 2023, Ossium Health Inc announced a $52 million Series C funding round led by its investor
基本信息
-
公司全称Ossium Health Inc
-
类型新药研发商
-
产业领域药品研发/制造、化学药
-
公司人数15~50人
-
地址25 Taylor Street SAN FRANCISCO CALIFORNIA 94102; US; Telephone: +14155135535;
-
联系电话14155135535
-
邮箱info@ossiumhealth.com
-
成立时间2016-01-01
投融资
-
2023-07-25C轮5200万美元First Round CapitalCPMGAsahi Kasei维梧资本Alumni VenturesManta Ray Ventures
-
2023-04-28捐赠/众筹/授予346万美元California Institute for Regenerative Medicine
-
2021-03-20B轮6300万美元Manta Ray VenturesGeneral CatalystFirst Round Capital
-
2016-12-30捐赠/众筹/授予未透露National Institutes of Health
-
2016-08-18未透露未透露First Round CapitalSquareFlatiron HealthUber
- 加载更多
相关投融资企业
A轮
Tasca Therapeuticstasca是一家私营生物技术公司，专注于发现和开发在癌症中很重要的自棕榈酰化靶蛋白的小分子抑制剂。该公司的主导项目CP-383是同类首创的候选药物，对多种癌症类型具有很好的临床前活性。
A轮
Ambrosia Biosciences Inc.是一家私营药物发现公司，开发口服小分子疗法治疗肥胖症和其他代谢紊乱。该公司的平台为体重管理和代谢健康提供非侵入性方法，与一些传统药物相比，使患者能够有效地管理自己的病情，副作用更少。
种子轮
RenaissThera is a pharmaceutical company focused on developing affordable and innovative therapies, particularly targeting high unmet medical needs in areas like cardio-metabolic disorders, oncology, and immunology. Additionally, Renaiss Thera utilizes generative AI to accelerate drug discovery and target identification.
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息